Go to Page # Page of 13
loading

Phase 1 Trial of Single and Multiple Dose Subcutaneously Administered Factor IX Variant ISU304/CB 2679d: Pharmacokinetics, Activity and Safety

 Chur Woo You MD PhD, Seung-Beom Hong PhD, Suyeong Kim, Ho-Jin Shin MD, Jin Seok Kim MD, Jung Woo Han
  7th-Jun-2018
Description: Phase 1 Trial of Single and Multiple Dose Subcutaneously Administered Factor IX Variant ISU304/CB 2679d: Pharmacokinetics, Activity and Safety.
Views: 1918
Domain: Medical
Category: Biotech/Pharma
Contents:
Phase 1 Trial of Single and Multiple Dose
Subcutaneously Administered Factor IX Variant
ISU304/CB 2679d: Pharmacokinetics, Activity
and Safety

Chur Woo You MD PhD, Seung-Beom Hong PhD, and Suyeong Kim MPharm,
Ho-Jin Shin MD, Jin Seok Kim MD, Jung Woo Han MD, Soo-Jeung Kim MD,
Do-Young Lee MD, Howard Levy MBBCh PhD

GLASGOW, SCOTLAND
22 May 2018

1

Disclosure for Chur Woo You
In compliance with ... See more

Recent Presentations

Yoojin Oh
20 September, 2019
...
19 September, 2019
...
18 September, 2019